Continuum of phenotypes and sympathoadrenal function in premature adrenarche

European Journal of Endocrinology

Volumn 160, Issue 4, 2009, Pages 657-665

  Utriainen, Pauliina ^a   Voutilainen, Raimo ^a   Jääskeläinen, Jarno ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANDROGEN; ANDROSTENEDIONE; CATECHOLAMINE; NORADRENALIN; PRASTERONE SULFATE; STEROID; CORTICOSTEROID; GONADOTROPIN;

ADRENAL FUNCTION; ADRENALIN BLOOD LEVEL; ADRENERGIC SYSTEM; ANDROGEN BLOOD LEVEL; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; HYPERANDROGENISM; MAJOR CLINICAL STUDY; MALE; NORADRENALIN BLOOD LEVEL; PHENOTYPE; PREMATURE ADRENARCHE; PRESCHOOL CHILD; PRIORITY JOURNAL; PUBERTY DISORDERS; SCHOOL CHILD; STEROID BLOOD LEVEL; ADRENAL DISEASE; ADRENAL GLAND; BIOSYNTHESIS; BLOOD; CONGENITAL ADRENAL HYPERPLASIA; GROWTH, DEVELOPMENT AND AGING; PATHOLOGY; PATHOPHYSIOLOGY; STATISTICAL ANALYSIS;

ADRENAL CORTEX HORMONES; ADRENAL GLAND DISEASES; ADRENAL GLANDS; ADRENAL HYPERPLASIA, CONGENITAL; ANDROGENS; CATECHOLAMINES; CHILD; DATA INTERPRETATION, STATISTICAL; FEMALE; GONADOTROPINS; HUMANS; MALE; PHENOTYPE; STEROIDS; SYMPATHETIC NERVOUS SYSTEM;

EID: 64549102567     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0367     Document Type: Article

References (46)

1. Albright F. Osteoporosis. Annals of Internal Medicine 1947 27 861-882.
2. Ibanez L, Dimartino-Nardi J, Potau N & Saenger P. Premature adrenarche - normal variant or forerunner of adult disease? Endocrine Reviews 2000 21 671-696.
3. Auchus RJ & Rainey WE. Adrenarche - physiology, biochemistry and human disease. Clinical Endocrinology 2004 60 288-296.
4. Dhom G. The prepubertal and pubertal growth of the adrenal (adrenarche). Beiträge zur Pathologie 1973 150 357-377.
5. Schiebinger RJ, Albertson BD, Cassorla FG, Bowyer DW, Geelhoed GW, Cutler GB Jr & Loriaux DL. The developmental changes in plasma adrenal androgens during infancy and adrenarche are associated with changing activities of adrenal microsomal 17-hydroxylase and 17,20-desmolase. Journal of Clinical Investigation 1981 67 1177-1182.
6. Gell JS, Carr BR, Sasano H, Atkins B, Margraf L, Mason JI & Rainey WE. Adrenarche results from development of a 3beta-hydroxysteroid dehydrogenase-deficient adrenal reticularis. Journal of Clinical Endocrinology and Metabolism 1998 83 3695-3701.
7. Suzuki T, Sasano H, Takeyama J, Kaneko C, Freije WA, Carr BR & Rainey WE. Developmental changes in steroidogenic enzymes in human postnatal adrenal cortex: immunohistochemical studies. Clinical Endocrinology 2000 53 739-747.
8. Rosenfield RL. Identifying children at risk for polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2007 92 787-796.
9. Silverman S, Migeon C, Rosemberg E & Wilkins L. Precocious growth of sexual hair without other secondary sexual development: 'premature pubarche' a constitutional variation of adolescence. Pediatrics 1952 10 426-432.
10. Korth-Schutz S, Levine LS & New MI. Serum androgens in normal prepubertal and pubertal children and in children with precocious adrenarche. Journal of Clinical Endocrinology and Metabolism 1976 42 117-124.
11. Voutilainen R, Perheentupa J & Apter D. Benign premature adrenarche: clinical features and serum steroid levels. Acta Paediatrica Scandinavica 1983 72 707-711.
12. Pere A, Perheentupa J, Peter M & Voutilainen R. Follow up of growth and steroids in premature adrenarche. European Journal of Pediatrics 1995 154 346-352.
13. Charkaluk M-L, Trivin C & Brauner R. Premature pubarche as an indicator of how body weight influences the onset of adrenarche. European Journal of Pediatrics 2004 163 89-93.
14. Zhang LH, Rodriguez H, Ohno S & Miller WL. Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome. PNAS 1995 92 10619-10623.
15. Vottero A, Capelletti M, Giuliodori S, Viani I, Ziveri M, Neri TM, Bernasconi S & Ghizzoni L. Decreased androgen receptor gene methylation in premature pubarche: a novel pathogenetic mechanism? Journal of Clinical Endocrinology and Metabolism 2006 91 968-972.
16. Likitmaskul S, Cowell CT, Donaghue K, Kreutzmann DJ, Howard NJ, Blades B & Silink M. 'Exaggerated adrenarche' in children presenting with premature adrenarche. Clinical Endocrinology 1995 42 265-272.
17. Banerjee S, Raghavan S, Wasserman EJ, Linder BL, Saenger P & Dimartino-Nardi J. Hormonal findings in African-American and Caribbean Hispanic girls with premature adrenarche: implications for polycystic ovarian syndrome. Pediatrics 1998 102 E36.
18. Therrell BL Jr, Berenbaum SA, Manter-Kapanke V, Simmank J, Korman K, Prentice L, Gonzalez J & Gunn S. Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia. Pediatrics 1998 101 583-590.
19. Jääskeläinen J, Levo A, Voutilainen R & Partanen J. Population-wide evaluation of disease manifestation in relation to molecular genotype in steroid 21-hydroxylase (CYP21) deficiency: good correlation in a well defined population. Journal of Clinical Endocrinology and Metabolism 1997 82 3293-3297.
20. Granoff AB, Chasalow FI & Blethen SL. 17-Hydroxyprogesterone responses to adrenocorticotropin in children with premature adrenarche. Journal of Clinical Endocrinology and Metabolism 1985 60 409-415.
21. Temeck JW, Pang S, Nelson C & New M. Genetic defects of steroidogenesis in premature pubarche. Journal of Clinical Endocrinology and Metabolism 1987 64 609-617.
22. Morris AH, Reiter EO, Geffner ME, Lippe BM, Itami RM & Mayes DM. Absence of nonclassical congenital adrenal hyperplasia in patients with precocious adrenarche. Journal of Clinical Endocrinology and Metabolism 1989 69 709-715.
23. Siegel SF, Finegold DN, Urban MD, McVie R & Lee PA. Premature pubarche: etiological heterogeneity. Journal of Clinical Endocrinology and Metabolism 1992 74 239-247.
24. Balducci R, Boscherini B, Mangiantini A, Morellini M & Toscano V. Isolated precocious pubarche: an approach. Journal of Clinical Endocrinology and Metabolism 1994 79 582-589.
25. Dacou-Voutetakis C & Dracopoulou M. High incidence of molecular defects of the CYP21 gene in patients with premature adrenarche. Journal of Clinical Endocrinology and Metabolism 1999 84 1570-1574.
26. Schinner S & Bornstein SR. Cortical-chromaffin cell interactions in the adrenal gland. Endocrine Pathology 2005 16 91-98.
27. Tenhola S, Martikainen A, Rahiala E, Parviainen M, Halonen P & Voutilainen R. Increased adrenocortical and adrenomedullary hormonal activity in 12-year-old children born small for gestational age. Journal of Pediatrics 2002 141 477-482.
28. Merke DP, Chrousos GP, Eisenhofer G,Weise M, Keil MF, Rogol AD, Van Wyk JJ & Bornstein SR. Adrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency. New England Journal of Medicine 2000 343 1362-1368.
29. Denburg MR, Silfen ME, Manibo AM, Chin D, Levine LS, Ferin M, McMahon DJ, Go C & Oberfield SE. Insulin sensitivity and the insulin-like growth factor system in prepubertal boys with premature adrenarche. Journal of Clinical Endocrinology and Metabolism 2002 87 5604-5609.
30. Utriainen P, Jääskeläinen J, Romppanen J & Voutilainen R. Childhood metabolic syndrome and its components in premature adrenarche. Journal of Clinical Endocrinology and Metabolism 2007 92 4282-4285.
31. Cole TJ, Freeman JV & Preece MA. Body mass index reference curves for the UK, 1990. Archives of Disease in Childhood 1995 73 25-29.
32. Pihkala J, Hakala T, Voutilainen P & Raivio K. New Finnish fetal growth charts (in Finnish). Duodecim 1989 105 1540-1546.
33. Tordjman K, Jaffe A, Trostanetsky Y, Greenman Y, Limor R & Stern N. Low-dose (1 microgram) adrenocorticotrophin (ACTH) stimulation as a screening test for impaired hypothalamopituitary-adrenal axis function: sensitivity, specificity and accuracy in comparison with the high-dose (250 microgram) test. Clinical Endocrinology 2000 52 633-640.
34. Arvat E, Di Vito L, Lanfranco F, Maccario M, Baffoni C, Rossetto R, Aimaretti G, Camanni F & Ghico E. Stimulatory effect of adrenocorticotropin on cortisol, aldosterone, and dehydroepiandrosterone secretion in normal humans: dose-response study. Journal of Clinical Endocrinology and Metabolism 2000 85 3141-3146.
35. Panamonta O, Thinkhamrop B, Kirdpon W, Pudtawaro LO & Sungsahachart D. Adrenocorticotropin stimulation test in congenital adrenal hyperplasia: comparison between standard and low dose test. Journal of the Medical Association of Thailand 2003 86 634-640.
36. Apter D, Pakarinen A, Hammond GL & Vihko R. Adrenocortical function in puberty: serum ACTH, cortisol and dehydroepiandrosterone in girls and boys. Acta Paediatrica Scandinavica 1979 68 599-604.
37. Turpeinen U, Itkonen O, Ahola L & Stenman UH. Determination of 17alpha-hydroxyprogesterone in serum by liquid chromatography-tandem mass spectrometry and immunoassay. Scandinavian Journal of Clinical and Laboratory Investigation 2005 65 3-12.
38. New MI, Lorenzen F, Lerner AJ, Kohn B, Oberfield SE, Pollack MS, Dupont B, Stoner E, Levy DJ, Pang S & Levine LS. Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. Journal of Clinical Endocrinology and Metabolism 1983 57 320-326.
39. Lashansky G, Saenger P, Fishman K, Gautier T, Mayes D, Berg G, Di Martino-Nardi J & Reiter E. Normative data for adrenal steroidogenesis in a healthy pediatric population: age- and sex-related changes after adrenocorticotropin stimulation. Journal of Clinical Endocrinology and Metabolism 1991 73 674-686.
40. Ibanez L, Potau N, Marcos MV & De Zegher F. Adrenal hyperandrogenism in adolescent girls with a history of low birthweight and precocious pubarche. Clinical Endocrinology 2000 53 523-527.
41. Flaa A, Mundal HH, Eide I, Kjeldsen S & Rostrup M. Sympathetic activity and cardiovascular risk factors in young men in the low, normal, and high blood pressure ranges. Hypertension 2006 47 396-402.
42. Flaa A, Eide IK, Kjeldsen SE & Rostrup M. Sympathoadrenal stress reactivity is a predictor of future blood pressure: an 18-year follow-up study. Hypertension 2008 52 336-341.
43. Berne C, Fagius J, Pollare T & Hjemdahl P. The sympathetic response to euglycaemic hyperinsulinaemia: evidence from microelectrode nerve recordings in healthy subjects. Diabetologia 1992 35 873-879.
44. Straznicky NE, Lambert EA, Lambert GW, Masuo K, Esler MD & Nestel PJ. Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome. Journal of Clinical Endocrinology and Metabolism 2005 90 5998-6005.
45. Tentolouris N, Liatis S & Katsilambros N. Sympathetic system activity in obesity and metabolic syndrome. Annals of the New York Academy of Sciences 2006 1083 129-152.
46. Zuckerman-Levin N, Tiosano D, Eisenhofer G, Bornstein S & Hochberg Z. The importance of adrenocortical glucocorticoids for adrenomedullary and physiological response to stress: a study in isolated glucocorticoid deficiency. Journal of Clinical Endocrinology and Metabolism 2001 86 5920-5924.